Please note: the information on this page is provided for informational purposes only. As of 2011, Simmons Hanly Conroy is no longer accepting cases involving Zyprexa.
Zyprexa (olanzapine) is a medication used to treat schizophrenia and bipolar disorder. It has sometimes been prescribed along with Prozac. The medication is manufactured by the company Eli Lilly & Co. Since 2001, serious side effects have been linked to its use.
Health Complications and Zyprexa Lawsuits
Potentially fatal Zyprexa side effects have led to a series of Zyprexa lawsuits over the years. Specifically, Zyprexa has been linked to:
- Heart failure
- Sudden death
Pneumonia has also been linked to use of Zyprexa. Because of the seriousness of the above health complications, Zyprexa lawsuits began to increase. Furthermore, a medical journal reported that the drug’s manufacturer Eli Lilly & Co. knew of the link to diabetes since 2001. The FDA required Lilly to print the warning label regarding diabetes risk in 2003.
Since 2011, Simmons Hanly Conroy no longer accepts Zyprexa cases. Learn more about past litigation areas of the pharmaceutical lawyers at the firm or explore more information on our current areas of litigation. Please contact us with any questions.
Shareholder Jayne Conroy served as a court-appointed member of the Plaintiffs’ Executive Committee Zyprexa Litigation, MDL 1596. Shareholder Andrea Bierstein also has national leadership experience with Zyprexa litigation.
I am so glad that my wife found the Simmons firm! Everyone has been fantastic and really good to me. I brag about the firm to everyone. Everyone at Simmons has so much goodness!